These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 7021291

  • 21. Beta-cell function and diabetic control in insulin dependent diabetes melletus.
    Faber OK.
    Acta Endocrinol Suppl (Copenh); 1985; 272():73-7. PubMed ID: 3914807
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Relation of immunoreactive gastric inhibitory polypeptide to changes in glycaemic control and B cell function in type 1 (insulin-dependent) diabetes mellitus.
    Krarup T, Madsbad S, Regeur L, Faber OK, Tronier B.
    Acta Endocrinol (Copenh); 1984 Feb; 105(2):221-5. PubMed ID: 6364671
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. C-peptide and insulin secretion in diabetes mellitus treated with oral hypoglycaemic agents or diet alone. A 3 years epidemiological cohort study on the Island of Falster, Denmark.
    Nielsen NV, Tronier B.
    Diabetes Res; 1987 Mar; 4(3):135-9. PubMed ID: 3301161
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Prevalence of residual B-cell function in insulin-treated diabetics evaluated by the plasma C-etide response to intravenous glucagon.
    Hendriksen C, Faber OK, Drejer J, Binder C.
    Diabetologia; 1977 Dec; 13(6):615-9. PubMed ID: 338408
    [Abstract] [Full Text] [Related]

  • 29. Serum magnesium in insulin-dependent diabetics and healthy subjects in relation to insulin secretion and glycemia during glucose-glucagon test.
    Menzel R, Pusch H, Ratzmann GW, Besch W, Förster F, Albrecht G, Ruhnke R.
    Exp Clin Endocrinol; 1985 Feb; 85(1):81-8. PubMed ID: 3886415
    [Abstract] [Full Text] [Related]

  • 30. C-peptide secretion and insulin antibodies as determinants of stability in diabetes mellitus.
    Yue DK, Baxter RC, Turtle JR.
    Metabolism; 1978 Jan; 27(1):35-44. PubMed ID: 619224
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Effect of strict blood glucose control on residual B-cell function in insulin-dependent diabetics.
    Madsbad S, Krarup T, Reguer L, Faber OK, Binder C.
    Diabetologia; 1981 May; 20(5):530-4. PubMed ID: 7026327
    [Abstract] [Full Text] [Related]

  • 34. Importance of insulin absorption, subcutaneous blood flow, and residual beta-cell function in insulin therapy.
    Lauritzen T, Binder C, Faber OK.
    Acta Paediatr Scand Suppl; 1980 May; 283():81-5. PubMed ID: 7010905
    [Abstract] [Full Text] [Related]

  • 35. Correlation between fasting serum C-peptide and B cell insulin secretory capacity in diabetes mellitus.
    Garcia-Webb P, Bonser A, Welborn TA.
    Diabetologia; 1982 Apr; 22(4):296. PubMed ID: 7047275
    [No Abstract] [Full Text] [Related]

  • 36. Insulin secretion in diabetes mellitus.
    Pfeifer MA, Halter JB, Porte D.
    Am J Med; 1981 Mar; 70(3):579-88. PubMed ID: 7011013
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. C-Peptide reserve in insulin-dependent diabetes. Comparative responses to glucose, glucagon and tolbutamide.
    Mirel RD, Ginsberg-Fellner F, Horwitz DL, Rayfield EJ.
    Diabetologia; 1980 Sep; 19(3):183-8. PubMed ID: 6997119
    [Abstract] [Full Text] [Related]

  • 40. Prevalence of residual B cell function and its metabolic consequences in Type 1 (insulin-dependent) diabetes.
    Madsbad S.
    Diabetologia; 1983 Mar; 24(3):141-7. PubMed ID: 6341142
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.